Lymphoma, B-Cell
- Name
- Lymphoma, B-Cell
- Accession Number
- DBCAT000176
- Description
Not Available
- Drugs
Drug Drug Description Ibritumomab tiuxetan A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. Tafasitamab A CD19-directed cytolytic monoclonal antibody used in the treatment of B-cell malignancies. - Drugs & Drug Targets
Drug Target Type Ibritumomab tiuxetan B-lymphocyte antigen CD20 target Tafasitamab B-lymphocyte antigen CD19 target